Opening a new era in cancer care, the Food and Drug Administration on Wednesday approved the first treatment that genetically engineers patients' own blood cells into an army of assassins to seek and destroy childhood leukemia.
By Lauren Neergaard, Associated Press
In our NewsHour Shares moment of the day, a program that enables critically and chronically ill children to be part of a sports team. Seven-year-old Ava loves to play soccer. When she was diagnosed with leukemia, she was sidelined from…
By PBS NewsHour
While more than 250 drugs were declared in short supply in the U.S. this past year, the latest worries centered on one called Methotrexate, considered essential for children battling leukemia. Ray Suarez discusses the problem and latest developments with Dr.
A look back at the life of Mary Travers, of the legendary folk trio Peter, Paul, and Mary, who died Wednesday at age 72.
By PBS NewsHour
Scientists have for the first time mapped the entire genome of a cancer patient, in the process finding eight new genetic mutations that led to the woman's leukemia.
By Admin, PBS NewsHour
In June, pharmaceutical giant Pfizer announced that it was investing $3 million in a small San Diego-based biotech startup called EyeCyte, which will work to develop adult stem cell-based treatments for eye diseases.
Uranium mining in Utah is gaining popularity, driven by efforts to find alternative energy sources to fossil fuels. The NewsHour reports on the growing uranium industry and its impact on the American fuel economy.
A Mt. Sinai report found 60 percent of Sept. 11 first responders who breathed contaminated dust and smoke at the World Trade Center attack site now suffer from respiratory problems. The NewsHour reports on lingering health problems and help given…
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.